These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 20594138

  • 1. Use of immunomodulators and biologic therapies in children with inflammatory bowel disease.
    Bousvaros A.
    Expert Rev Clin Immunol; 2010 Jul; 6(4):659-66. PubMed ID: 20594138
    [Abstract] [Full Text] [Related]

  • 2. [Biological therapy as treatment of inflammatory bowel diseases].
    Agnholt J.
    Ugeskr Laeger; 2008 Jun 09; 170(24):2152-6. PubMed ID: 18565302
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Management of inflammatory bowel disease in adults.
    Katz JA.
    J Dig Dis; 2007 May 09; 8(2):65-71. PubMed ID: 17532817
    [Abstract] [Full Text] [Related]

  • 6. Inflammatory bowel disease therapy: current state-of-the-art.
    Blonski W, Buchner AM, Lichtenstein GR.
    Curr Opin Gastroenterol; 2011 Jul 09; 27(4):346-57. PubMed ID: 21654383
    [Abstract] [Full Text] [Related]

  • 7. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M.
    Dig Liver Dis; 2005 Jun 09; 37(6):407-17. PubMed ID: 15893279
    [Abstract] [Full Text] [Related]

  • 8. Medical management of patients with difficult-to-treat inflammatory bowel disease.
    van Hogezand RA.
    Neth J Med; 1994 Aug 09; 45(2):55-9. PubMed ID: 7936006
    [Abstract] [Full Text] [Related]

  • 9. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J, Grancher K, Mandel F, Daum F.
    Am J Gastroenterol; 1993 Jan 09; 88(1):44-8. PubMed ID: 8420272
    [Abstract] [Full Text] [Related]

  • 10. Review article: chronic active disease and maintaining remission in Crohn's disease.
    Kamm MA.
    Aliment Pharmacol Ther; 2004 Oct 09; 20 Suppl 4():102-5. PubMed ID: 15352904
    [Abstract] [Full Text] [Related]

  • 11. Immunosuppressive therapy of inflammatory bowel disease: a historical perspective.
    Korelitz BI.
    Gastroenterologist; 1995 Jun 09; 3(2):141-52. PubMed ID: 7640945
    [Abstract] [Full Text] [Related]

  • 12. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
    Roblin X, Serre-Debeauvais F, Phelip JM, Faucheron JL, Hardy G, Chartier A, Helluwaert F, Bessard G, Bonaz B.
    Aliment Pharmacol Ther; 2005 Apr 01; 21(7):829-39. PubMed ID: 15801918
    [Abstract] [Full Text] [Related]

  • 13. The appropriateness of concomitant immunomodulators with anti-tumor necrosis factor agents for Crohn's disease: one size does not fit all.
    Melmed GY, Spiegel BM, Bressler B, Cheifetz AS, Devlin SM, Harrell LE, Irving PM, Jones J, Kaplan GG, Kozuch PL, Velayos FS, Baidoo L, Sparrow MP, Siegel CA.
    Clin Gastroenterol Hepatol; 2010 Aug 01; 8(8):655-9. PubMed ID: 20451665
    [Abstract] [Full Text] [Related]

  • 14. Review article: monitoring of immunomodulators in inflammatory bowel disease.
    Aberra FN, Lichtenstein GR.
    Aliment Pharmacol Ther; 2005 Feb 15; 21(4):307-19. PubMed ID: 15709982
    [Abstract] [Full Text] [Related]

  • 15. Update on idiopathic colitides.
    Strobel S, Abreu MT.
    Curr Opin Gastroenterol; 2013 Jan 15; 29(1):60-5. PubMed ID: 23207597
    [Abstract] [Full Text] [Related]

  • 16. Are patients with inflammatory bowel disease receiving optimal care?
    Reddy SI, Friedman S, Telford JJ, Strate L, Ookubo R, Banks PA.
    Am J Gastroenterol; 2005 Jun 15; 100(6):1357-61. PubMed ID: 15929770
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Toxicity of infliximab in the course of treatment of Crohn's disease.
    Bratcher JM, Korelitz BI.
    Expert Opin Drug Saf; 2006 Jan 15; 5(1):9-16. PubMed ID: 16370952
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 6-Mercaptopurine and other immunosuppressive agents in the treatment of Crohn's disease and ulcerative colitis.
    Present DH.
    Gastroenterol Clin North Am; 1989 Mar 15; 18(1):57-71. PubMed ID: 2646222
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.